Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11797 | 953 | 31.0 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
109 | 3 | RECTAL CANCER//COLORECTAL CANCER//COLONOSCOPY | 71522 |
1176 | 2 | THYMIDYLATE SYNTHASE//THYMIDINE PHOSPHORYLASE//5 FLUOROURACIL | 9333 |
11797 | 1 | THYMIDINE PHOSPHORYLASE//PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR//TAS 102 | 953 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THYMIDINE PHOSPHORYLASE | authKW | 6745301 | 34% | 64% | 328 |
2 | PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR | authKW | 1868964 | 7% | 83% | 70 |
3 | TAS 102 | authKW | 988646 | 4% | 86% | 36 |
4 | THYMIDINE PHOSPHORYLASE INHIBITOR | authKW | 770185 | 3% | 96% | 25 |
5 | 5 DEOXY 5 FLUOROURIDINE | authKW | 655090 | 3% | 66% | 31 |
6 | PD ECGF | authKW | 584148 | 3% | 65% | 28 |
7 | GLIOSTATIN | authKW | 450558 | 2% | 94% | 15 |
8 | DOXIFLURIDINE | authKW | 431657 | 3% | 42% | 32 |
9 | PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE | authKW | 292922 | 2% | 57% | 16 |
10 | TRIFLUOROTHYMIDINE | authKW | 241224 | 2% | 47% | 16 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 9919 | 53% | 0% | 501 |
2 | Chemistry, Medicinal | 379 | 7% | 0% | 63 |
3 | Pharmacology & Pharmacy | 359 | 14% | 0% | 130 |
4 | Pathology | 84 | 3% | 0% | 32 |
5 | Biochemistry & Molecular Biology | 65 | 12% | 0% | 111 |
6 | Gastroenterology & Hepatology | 56 | 3% | 0% | 30 |
7 | Obstetrics & Gynecology | 26 | 2% | 0% | 23 |
8 | Biophysics | 23 | 3% | 0% | 28 |
9 | Medicine, Research & Experimental | 22 | 3% | 0% | 29 |
10 | Rheumatology | 20 | 1% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KAJIWARA 200 | 96119 | 0% | 100% | 3 |
2 | MED BIOREGULAT MIZUHO KU | 96119 | 0% | 100% | 3 |
3 | MOL ONCOLFIELD ONCOL | 64080 | 0% | 100% | 2 |
4 | UROLFIELD ONCOL | 64080 | 0% | 100% | 2 |
5 | CYTOSTAT GRP | 51259 | 0% | 40% | 4 |
6 | TOKUSHIMA | 45985 | 2% | 7% | 21 |
7 | ST NIKOLAS HISTOPATHOL UNIT | 42718 | 0% | 67% | 2 |
8 | AUBU KU | 32040 | 0% | 100% | 1 |
9 | BIOREGULAT MIZUHO KU | 32040 | 0% | 100% | 1 |
10 | CANC UKMOL ANGIOGENESIS GRP | 32040 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOLOGY REPORTS | 9731 | 6% | 1% | 55 |
2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 3145 | 3% | 0% | 27 |
3 | ANTICANCER RESEARCH | 2907 | 4% | 0% | 42 |
4 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2198 | 2% | 0% | 18 |
5 | JAPANESE JOURNAL OF CANCER RESEARCH | 2011 | 2% | 0% | 15 |
6 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1902 | 3% | 0% | 24 |
7 | BRITISH JOURNAL OF CANCER | 1676 | 3% | 0% | 31 |
8 | CANCER LETTERS | 1249 | 2% | 0% | 22 |
9 | CLINICAL CANCER RESEARCH | 1011 | 2% | 0% | 22 |
10 | ANTI-CANCER DRUGS | 964 | 1% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMIDINE PHOSPHORYLASE | 6745301 | 34% | 64% | 328 | Search THYMIDINE+PHOSPHORYLASE | Search THYMIDINE+PHOSPHORYLASE |
2 | PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR | 1868964 | 7% | 83% | 70 | Search PLATELET+DERIVED+ENDOTHELIAL+CELL+GROWTH+FACTOR | Search PLATELET+DERIVED+ENDOTHELIAL+CELL+GROWTH+FACTOR |
3 | TAS 102 | 988646 | 4% | 86% | 36 | Search TAS+102 | Search TAS+102 |
4 | THYMIDINE PHOSPHORYLASE INHIBITOR | 770185 | 3% | 96% | 25 | Search THYMIDINE+PHOSPHORYLASE+INHIBITOR | Search THYMIDINE+PHOSPHORYLASE+INHIBITOR |
5 | 5 DEOXY 5 FLUOROURIDINE | 655090 | 3% | 66% | 31 | Search 5+DEOXY+5+FLUOROURIDINE | Search 5+DEOXY+5+FLUOROURIDINE |
6 | PD ECGF | 584148 | 3% | 65% | 28 | Search PD+ECGF | Search PD+ECGF |
7 | GLIOSTATIN | 450558 | 2% | 94% | 15 | Search GLIOSTATIN | Search GLIOSTATIN |
8 | DOXIFLURIDINE | 431657 | 3% | 42% | 32 | Search DOXIFLURIDINE | Search DOXIFLURIDINE |
9 | PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE | 292922 | 2% | 57% | 16 | Search PYRIMIDINE+NUCLEOSIDE+PHOSPHORYLASE | Search PYRIMIDINE+NUCLEOSIDE+PHOSPHORYLASE |
10 | TRIFLUOROTHYMIDINE | 241224 | 2% | 47% | 16 | Search TRIFLUOROTHYMIDINE | Search TRIFLUOROTHYMIDINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LIEKENS, S , BRONCKAERS, A , GAGO, F , BALZARINI, J , (2009) THE DUAL ROLE OF THYMIDINE PHOSPHORYLASE IN CANCER DEVELOPMENT AND CHEMOTHERAPY.MEDICINAL RESEARCH REVIEWS. VOL. 29. ISSUE 6. P. 903 -953 | 237 | 65% | 70 |
2 | BERA, H , CHIGURUPATI, S , (2016) RECENT DISCOVERY OF NON-NUCLEOBASE THYMIDINE PHOSPHORYLASE INHIBITORS TARGETING CANCER.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 124. ISSUE . P. 992 -1003 | 89 | 81% | 0 |
3 | LIEKENS, S , BRONCKAERS, A , PEREZ-PEREZ, MJ , BALZARINI, J , (2007) TARGETING PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR THYMIDINE PHOSPHORYLASE FOR CANCER THERAPY.BIOCHEMICAL PHARMACOLOGY. VOL. 74. ISSUE 11. P. 1555-1567 | 85 | 82% | 44 |
4 | PEREZ-PEREZ, MJ , PRIEGO, EM , HERNANDEZ, AI , CAMARASA, MJ , BALZARINI, J , LIEKENS, S , (2005) THYMIDINE PHOSPHORYLASE INHIBITORS: RECENT DEVELOPMENTS AND POTENTIAL THERAPEUTIC APPLICATIONS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 5. ISSUE 12. P. 1113-1123 | 58 | 94% | 28 |
5 | PETERS, GJ , (2015) THERAPEUTIC POTENTIAL OF TAS-102 IN THE TREATMENT OF GASTROINTESTINAL MALIGNANCIES.THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. VOL. 7. ISSUE 6. P. 340 -356 | 55 | 71% | 3 |
6 | COLE, C , FOSTER, AJ , FREEMAN, S , JAFFAR, M , MURRAY, PE , STRATFORD, IJ , (1999) THE ROLE OF THYMIDINE PHOSPHORYLASE/PD-ECGF IN CANCER CHEMOTHERAPY: A CHEMICAL PERSPECTIVE.ANTI-CANCER DRUG DESIGN. VOL. 14. ISSUE 5. P. 383-392 | 60 | 77% | 19 |
7 | AKIYAMA, S , FURUKAWA, T , SUMIZAWA, T , TAKEBAYASHI, Y , NAKAJIMA, Y , SHIMAOKA, S , HARAGUCHI, M , (2004) THE ROLE OF THYMIDINE PHOSPHORYLASE,, AN ANGIOGENIC ENZYME, IN TUMOR PROGRESSION.CANCER SCIENCE. VOL. 95. ISSUE 11. P. 851-857 | 42 | 82% | 56 |
8 | TOI, M , RAHMAN, MA , BANDO, H , CHOW, LWC , (2005) THYMIDINE PHOSPHORYLASE (PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH FACTOR) IN CANCER BIOLOGY AND TREATMENT.LANCET ONCOLOGY. VOL. 6. ISSUE 3. P. 158-166 | 50 | 60% | 89 |
9 | UBOHA, N , HOCHSTER, HS , (2016) TAS-102: A NOVEL ANTIMETABOLITE FOR THE 21ST CENTURY.FUTURE ONCOLOGY. VOL. 12. ISSUE 2. P. 153 -163 | 36 | 72% | 0 |
10 | KUBIAK, R , MISZCZAK-ZABORSKA, E , SMOLAREK, M , WOJCIK-KROWIRANDA, K , BARTKOWIAK, J , (2009) THE THYMIDINE PHOSPHORYLASE AS THE PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR OF ENDOMETRIAL CANCER.GINEKOLOGIA POLSKA. VOL. 80. ISSUE 8. P. 596 -601 | 34 | 87% | 0 |
Classes with closest relation at Level 1 |